Children and adults aged 12-64 years with a clinical diagnosis of atopic dermatitis (AD) are needed for this clinical research trial. Eligible participants must have experienced symptoms for at least 3 years. Participants also must either have a history of inadequate response to previous systemic treatments for AD, or that other systemic treatments have been medically inadviseable.
All participants will receive investigational oral or subcutaneous injection (SC) treatments (active study drugs) during the treatment period. Study medication and study-related assessments may be provided at no cost. Should you qualify for this study, you may be reimbursed for travel expenses that you incur for each completed study visit.
Study participation will be approximately 41 weeks and involve about 10 visits to the study centre.
If interested, please contact our Research Coordinator at 416-633-0001 x 4 or e-mail [email protected].
